Our news journalists obtained a quote from the research from
According to the news editors, the research concluded: "Efforts to identify the quantity and quality of clonal selection and genomic variability through modern genomic profiling led successfully to new insights into targeted treatment with more effective drugs and the promise to overcome resistance.SummaryMultigene approaches and novel microarray platforms such as the next-generation sequencing technology are feasible in clinical practice in order to assess the prognosis more precisely and to identify new molecular targets for developing more effective drugs in the near future."
For more information on this research see: Using molecular profiles to tailor treatment in breast cancer: are they ready for prime time? Current Opinion in Obstetrics & Gynecology, 2014;26(1):21-26. Current Opinion in Obstetrics & Gynecology can be contacted at:
Our news journalists report that additional information may be obtained by contacting F. Peintinger,
Keywords for this news article include:
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC
Most Popular Stories
- Americans Still Pessimistic Despite Economic Growth
- Apple to Unveil New Items on Sept. 9
- Bogdanovitch Delivers Laughs With 'She's Funny'
- Nintendo Launching 'Amiibo' Toy-game Franchise
- Parra Joins Exclusive Club of Hispanic CEOs
- Axxis Solutions Appoints Benites as CEO
- Friends Followed Similar Paths to Violent Jihad
- Labor Day Travel Up, Gas Prices Down
- U.K. Raises Terror Threat Level to 'Severe'
- Obama Puts Ukraine Violence on Russia